Peter Newmark

4.7k total citations · 2 hit papers
161 papers, 2.5k citations indexed

About

Peter Newmark is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Reproductive Medicine. According to data from OpenAlex, Peter Newmark has authored 161 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Public Health, Environmental and Occupational Health and 9 papers in Reproductive Medicine. Recurrent topics in Peter Newmark's work include Science, Research, and Medicine (9 papers), Biotechnology and Related Fields (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Peter Newmark is often cited by papers focused on Science, Research, and Medicine (9 papers), Biotechnology and Related Fields (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Peter Newmark collaborates with scholars based in United Kingdom, Spain and France. Peter Newmark's co-authors include Royal L. Tinsley, Maureen T. Krause, Ralph Green, D. L. Mollin, John O’Brien, Fiona Godlee, Pritpal S Tamber, Gunilla Anderman, Margaret Rogers and A Minty and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Newmark

143 papers receiving 1.8k citations

Hit Papers

A textbook of translation 1983 2026 1997 2011 1988 1983 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Newmark United Kingdom 15 1.7k 546 383 311 269 161 2.5k
Allan Bell New Zealand 19 1.8k 1.0× 248 0.5× 704 1.8× 472 1.5× 91 0.3× 51 3.6k
William A. Foley Australia 17 1.2k 0.7× 257 0.5× 410 1.1× 81 0.3× 27 0.1× 38 1.8k
Hansjörg Schmid Germany 25 885 0.5× 265 0.5× 578 1.5× 70 0.2× 7 0.0× 95 2.0k
Fiona Hyland United States 24 2.0k 1.1× 130 0.2× 79 0.2× 101 0.3× 83 0.3× 61 4.3k
George A. Miller United States 6 435 0.2× 109 0.2× 527 1.4× 94 0.3× 32 0.1× 14 1.6k
Monika Bednarek Australia 26 714 0.4× 261 0.5× 503 1.3× 774 2.5× 41 0.2× 71 2.3k
Christian Mair Germany 20 993 0.6× 216 0.4× 174 0.5× 58 0.2× 10 0.0× 57 1.5k
Alan G. Gross United States 18 119 0.1× 79 0.1× 190 0.5× 132 0.4× 39 0.1× 95 1.4k
Guo-Ming Chen China 19 374 0.2× 9 0.0× 67 0.2× 1.1k 3.4× 62 0.2× 71 2.2k
Mike Baynham United Kingdom 17 430 0.2× 18 0.0× 79 0.2× 49 0.2× 55 0.2× 53 1.2k

Countries citing papers authored by Peter Newmark

Since Specialization
Citations

This map shows the geographic impact of Peter Newmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Newmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Newmark more than expected).

Fields of papers citing papers by Peter Newmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Newmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Newmark. The network helps show where Peter Newmark may publish in the future.

Co-authorship network of co-authors of Peter Newmark

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Newmark. A scholar is included among the top collaborators of Peter Newmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Newmark. Peter Newmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newmark, Peter, et al.. (2022). Tradução não literária à luz da tradução literária. Macedonian Journal of Medical Sciences (University of Skopje). 11(1). 1–7.
2.
Newmark, Peter. (2015). Who nurtured Nature?. Current Biology. 25(22). R1060–R1061. 1 indexed citations
3.
Tamber, Pritpal S, Fiona Godlee, & Peter Newmark. (2003). Open access to peer-reviewed research: making it happen. The Lancet. 362(9395). 1575–1577. 21 indexed citations
4.
Anderman, Gunilla, Margaret Rogers, & Peter Newmark. (1999). Word, text, translation : liber amicorum for Peter Newmark. Multilingual Matters eBooks. 14 indexed citations
5.
Newmark, Peter. (1995). A correlative Approach to Translation. Dialnet (Universidad de la Rioja). 33–42. 1 indexed citations
6.
Newmark, Peter. (1992). Manual de traducción. 21 indexed citations
7.
Newmark, Peter. (1988). Pragmatic translation and literalism. TTR traduction terminologie rédaction. 1(2). 133–133. 14 indexed citations
8.
Newmark, Peter. (1988). Bark Extract Amplifies Vaccines. Nature Biotechnology. 6(1). 23–23. 3 indexed citations
9.
Newmark, Peter. (1988). Two European Companies Market Lipases. Nature Biotechnology. 6(4). 369–369. 6 indexed citations
10.
Newmark, Peter. (1986). Seeing the way to B-cell growth. Nature. 319(6055). 620–620. 1 indexed citations
11.
Newmark, Peter. (1986). Colombian immunology: More plans for malaria vaccine. Nature. 321(6072). 721–721. 1 indexed citations
12.
Newmark, Peter. (1986). An image of science and business. Nature. 320(6060). 318–318. 2 indexed citations
13.
Newmark, Peter. (1983). Oncogenic intelligence: A new member of the ras family. Nature. 303(5912). 20–20. 5 indexed citations
14.
Newmark, Peter. (1983). Oncogenic intelligence: Viral oncogene permutations. Nature. 306(5942). 426–426. 6 indexed citations
15.
Newmark, Peter. (1983). Oncogenic intelligence: The rasmatazz of cancer genes. Nature. 305(5934). 470–471. 9 indexed citations
16.
Newmark, Peter. (1983). Oncogenic intelligence: Polymorphism or oncogene?. Nature. 301(5902). 654–655. 1 indexed citations
17.
Newmark, Peter. (1981). Interferon: decline and stall. Nature. 291(5811). 105–106. 10 indexed citations
18.
Newmark, Peter. (1981). Benefits and snags of yeast plasmids. Nature. 290(5802). 77–77. 1 indexed citations
19.
Newmark, Peter. (1978). WHO looks for benefits from genetic engineering. Nature. 272(5655). 663–664. 2 indexed citations
20.
Newmark, Peter. (1976). Eukaryotic genome structure and function in Tehran. Nature. 261(5561). 544–545. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026